期刊文献+

卵巢成熟畸胎瘤与糖抗原199、125相关分析 被引量:2

Correlation factor analysis of mature ovarian teratom and serum CA199 and serum CA125
下载PDF
导出
摘要 目的:探讨CA199、CA125与卵巢成熟畸胎瘤的相关性及对其诊断和鉴别诊断价值。方法:分析卵巢成熟畸胎瘤276例患者年龄、术前CA199、CA125检测值、术中肿瘤的数量、大小、分布情况及相关性。结果:(1)276例中CA199阳性85例(30.80%);CA125阳性34例(12.32%);两者均为阳性者18例(6.5%)。两者阳性数比较差异有高度统计学意义(P〈0.001)。(2)成熟畸胎瘤单侧236例,CA199阳性63例,CA125阳性27例。双侧成熟畸胎瘤40例中CA199阳性22例,CA125阳性7例。(3)平均体积为159.33±221.11cm3,瘤体直径>10cm 31例,6~10cm 102例,≤5cm 143例,瘤体直径越大,阳性检出率越高。(4)不同年龄段CA199、CA125的阳性率呈降低趋势,年龄越小,CA199、CA125阳性率越高。结论:卵巢成熟畸胎瘤可导致血清CA199、CA125血清表达升高,但CA199检测有更高临床意义。 Objective:To investigate the correlation between mature ovarian teratoma and the levels of CA199 and CA125. Method:The correlation among the factors including ages, values of CA199 and CA125 before the surgery, and the numbers, sizes and distribution of the tumours during the surgery of 276 patients suffering from mature ovarian teratomas was retrospectively analysed. Result: The overall rates for CA199 and CA125 in the serum tested positive were 30.80%and 12.32%, respectively, which indicated correlation between the numbers, sizes and distribution of the teratomas and the ages of patients. The younger the patients with larger volumes of teratomas or/and bilateral teratomas of ovaries, the higher the level of CA199 and CA125. Conclusion: The detection of CA199 and CA125 is advantageous in the diagnoses and i-dentification of mature ovarian teratomas. However, the detection of CA199 is of more clinical value.
出处 《交通医学》 2013年第5期446-448,共3页 Medical Journal of Communications
关键词 卵巢肿瘤 畸胎瘤 糖抗原199 糖抗原125 卵巢上皮样肿瘤标记物 ovarian tumor teratoma serum CA199 serum CA125 tumor markers of epithelial ovarian tumor
  • 相关文献

参考文献7

二级参考文献12

  • 1龚晓明,冷金花,郎景和,黄荣丽,刘珠凤,孙大为,朱兰.卵巢成熟畸胎瘤695例临床分析[J].中国医学科学院学报,2004,26(6):692-695. 被引量:51
  • 2连利娟,刘丹华,刘炽明,等.妇科肿瘤学[M].2版.北京:人民卫生出版社,1996:460-499.
  • 3Ishigam IS,Natsugoe S,Hokita S,et al.Clinical importance of preoperative carcino embryonic antigen and carbohydrate antigen 199 levels in gastric cancer[J].J Clin Gastro,2001,32(1):41-44.
  • 4Mann DV,Edwards R,Ho S,et al.Elevated tumor marker CA199:Clinical interpretation and influence of obstructive jaundice[J].Eur J Surg Ocol,2000,26:471-479.
  • 5Nanayakkara S, Ali S, Gilmour K. Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst[J]. J Obstet Gynaecol ,2007,27 ( 1 ) :96-97.
  • 6Atabekoglu C, Bozaci EA, Tezcan S. Elevated carbohydrate antigen 19-9 in a dermoid cyst[ J]. lnt J Gynaecol Obstet,2005,91( 3 ) :262-263.
  • 7Mikuni M, Makinoda S, Tanaka T, et al. Evaluation of tumor marker in ovarian dermoid cyst[ J ]. Nippon Sanka Fujinka Gakkai Zasshi, 1990,42 (5) :479-484.
  • 8Emin U, Tayfun G, Cantekin I, et al. Tumor markers in mature cystic teratomas of the cyats [J]. Arch Gyneeol Obstet, 2009, 279 : 145-147.
  • 9Coskun A, Kiran G, Ozdemir O. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts[ J]. Clin Exp Obstet Gynecol, 2008,35(2) :137-139.
  • 10Ito K. Significance of CA19-9 in mature cystic teratoma[ J]. Nippon Sanka Fujinka Gakkai Zasshi, 1992,44 (5) :524-528.

共引文献312

同被引文献48

  • 1陈晨,李俊东,黄鹤,冯艳玲,王銮虹,陈亮.肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值[J].癌症,2008,27(1):92-95. 被引量:44
  • 2Kataoka T, Watanabe Y, Hoshiai H. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma [J]. J Obstet Gynaecol Res,2012,38(8) :1071-1076.
  • 3Emin U,Taflun G,Cantekin I,et al. Tumor markers in mature cystic tera- tomas of the ovary[J]. Arch Gynecol Obstet ,2009,279(2) :145-147.
  • 4Dede M, Gungor S, Yenen MC, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary [ J]. Int J Gyne- col Cancer, 2006, 16 (1): 189-193.
  • 5Coskun A, Kiran G, Ozdemir O. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts [ J ]. Clin Exp Obstet Gynecol, 2008, 35 (2): 137-139.
  • 6Atabekoglu C, Bozaci EA, Tezcan S. Elevated carbohydrate antigen 19-9 in a dermoid cyst [J]. Int J Gynaecol Obstet, 2005, 91 (3) : 262-263.
  • 7Kim M J, Kim NY, Lee DY, et al. Clinical characteristics of ovari- an teratoma: age-focused retrospective analysis of 580 cases [ J]. Am J Obstet Gynecol, 2011, 205 (1) : 31-32.
  • 8Kikkawa F, Nawa A, Tamakoshi K, et al. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary [ J]. Cancer, 1998, 82 (11): 2249-2255.
  • 9Ito K. CA19-9 in mature cystic teratoma [J]. Tohoku J Exp Med, 1994, 172 (2): 133-138.
  • 10池鸿斐,金楚,林凤.常规肿瘤标记物在卵巢成熟囊性畸胎瘤中的诊断意义[J].中国妇幼保健,2009,24(13):1855-1857. 被引量:7

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部